For heavy vapers or people who have relapsed on cold turkey or NRT, prescription medications shift the odds meaningfully. Three drugs have solid randomised-trial evidence for stopping nicotine: varenicline, bupropion, and cytisine. All are used off-label for vaping, all require a prescriber, and all work best paired with behavioural support.
Varenicline (Chantix / Champix)
Varenicline is a partial agonist at the α4β2 nicotinic acetylcholine receptor — the receptor nicotine binds to. It occupies the receptor enough to blunt withdrawal, while blocking nicotine from binding fully if you slip. That combination reduces both craving intensity and the reward from a lapse.
Effect size. In the 2023 Cochrane network meta-analysis, varenicline roughly triples six-month quit rates versus placebo and beats single-form NRT. It matches or slightly exceeds combination NRT.
Course. Start 1-2 weeks before quit day, ramp the dose over a week, continue for 12 weeks (24 in some protocols).
Side effects. Vivid dreams, mild nausea, headaches. A boxed warning about mood changes was removed by the FDA in 2016 after large trials failed to show a psychiatric risk.
See our full varenicline explainer.
Bupropion (Zyban / Wellbutrin)
Bupropion is a norepinephrine-dopamine reuptake inhibitor originally developed as an antidepressant. Its cessation effect is thought to come from smoothing the dopamine dip that drives withdrawal.
Effect size. Comparable to single-form NRT in Cochrane data; less than varenicline. Often chosen when varenicline is contraindicated or when the quitter also has depression.
Course. Start 1-2 weeks before quit day, continue for 7-12 weeks.
Side effects and contraindications. Insomnia, dry mouth. Contraindicated in seizure disorders, current or past eating disorders, and heavy alcohol use.
See our full bupropion explainer.
Cytisine (Tabex)
Cytisine is a partial nicotinic agonist derived from the laburnum plant. Same mechanism as varenicline; different molecule, much cheaper, and on the WHO essential medicines list.
Effect size. A 2024 head-to-head trial found cytisine non-inferior to varenicline. Cochrane rates it more effective than placebo and comparable to NRT.
Availability. OTC in parts of Eastern Europe; prescription in the UK; not yet FDA-approved in the US as of 2026.
See our full cytisine explainer.
Choosing between them
There is no single best drug; the right choice depends on medical history, cost, availability, and what you have tried before. Our comparison table walks through the decision in one page.
A rough guide:
- First attempt, no contraindications: varenicline (or cytisine where available).
- Concurrent depression: bupropion.
- Cost-constrained or overseas: cytisine.
- Previously failed on medication: combination NRT + behavioural support, sometimes stacked with a medication.
How to get a prescription
Any primary care clinician, telehealth service, or state quitline can prescribe. Bring:
- Your daily nicotine intake (mg/mL × mL per day).
- Your quit history (previous attempts, what worked, what did not).
- Your medical history (seizures, mood conditions, cardiac history).
- A tentative quit date, one to two weeks out.
Our prescription walkthrough covers the specific questions to ask.
Medications are not magic
The best trials still show absolute one-year quit rates of 20-30% on medication versus 5-10% on placebo. That is a big relative improvement and a modest absolute one. Medication makes withdrawal manageable; it does not remove the cue-driven cravings that trigger most relapses. Pair a prescription with a real craving plan, a quit date, and behavioural support and the odds compound.
